Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjun Sahgal

Showing results (531-540 of 648) with videos related to

Pageof 65
Sort By:
JAMA Oncology|October 15, 2020
Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain MetastasesKerstin A Eitz, Simon S Lo, Hany Soliman, et al.
Cancer|February 7, 2018
Psychometric evaluation and adaptation of the Spine Oncology Study Group Outcomes Questionnaire to evaluate health-related quality of life in patients with spinal metastasesAnne L Versteeg, Arjun Sahgal, Laurence D Rhines, et al.
International Journal of Radiation Oncology, Biology, Physics|March 28, 2025
Temporal Apparent Diffusion Coefficient Changes During Chemoradiation: An Imaging Biomarker for Tumor Response Monitoring and Spatial Recurrence Prediction in GlioblastomaDaniel Moore-Palhares, Liam S P Lawrence, Sten Myrehaug, et al.
Cancers|January 1, 2021
The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain MetastasesTyler Gutschenritter, Vyshak A Venur, Stephanie E Combs, et al.
Neuro-Oncology|May 6, 2020
Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV GliomasDenise Bernhardt, Wolfgang Wick, Stephanie E Weiss, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2018
Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic PathwaysMichael T Milano, Jimm Grimm, Scott G Soltys, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 12, 2013
Predictive factors of overall quality of life in advanced cancer patients using EORTC QLQ-C30Gemma Cramarossa, Liang Zeng, Liying Zhang, et al.
Cancer|September 7, 2019
Patient satisfaction with treatment outcomes after surgery and/or radiotherapy for spinal metastasesAnne L Versteeg, Arjun Sahgal, Norio Kawahara, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2021
Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting StandardsScott G Soltys, Jimm Grimm, Michael T Milano, et al.
Neurospine|February 7, 2022
Steroids in the Management of Preoperative Neurological Deficits in Metastatic Spine Disease: Results From the EPOSO StudyAnne L Versteeg, Lior M Elkaim, Arjun Sahgal, et al.
Pageof 65

Showing results (531-540 of 648) with videos related to

Sort By:
Pageof 65
JAMA Oncology|October 15, 2020
Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain MetastasesKerstin A Eitz, Simon S Lo, Hany Soliman, et al.
Cancer|February 7, 2018
Psychometric evaluation and adaptation of the Spine Oncology Study Group Outcomes Questionnaire to evaluate health-related quality of life in patients with spinal metastasesAnne L Versteeg, Arjun Sahgal, Laurence D Rhines, et al.
International Journal of Radiation Oncology, Biology, Physics|March 28, 2025
Temporal Apparent Diffusion Coefficient Changes During Chemoradiation: An Imaging Biomarker for Tumor Response Monitoring and Spatial Recurrence Prediction in GlioblastomaDaniel Moore-Palhares, Liam S P Lawrence, Sten Myrehaug, et al.
Cancers|January 1, 2021
The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain MetastasesTyler Gutschenritter, Vyshak A Venur, Stephanie E Combs, et al.
Neuro-Oncology|May 6, 2020
Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV GliomasDenise Bernhardt, Wolfgang Wick, Stephanie E Weiss, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2018
Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic PathwaysMichael T Milano, Jimm Grimm, Scott G Soltys, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 12, 2013
Predictive factors of overall quality of life in advanced cancer patients using EORTC QLQ-C30Gemma Cramarossa, Liang Zeng, Liying Zhang, et al.
Cancer|September 7, 2019
Patient satisfaction with treatment outcomes after surgery and/or radiotherapy for spinal metastasesAnne L Versteeg, Arjun Sahgal, Norio Kawahara, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2021
Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting StandardsScott G Soltys, Jimm Grimm, Michael T Milano, et al.
Neurospine|February 7, 2022
Steroids in the Management of Preoperative Neurological Deficits in Metastatic Spine Disease: Results From the EPOSO StudyAnne L Versteeg, Lior M Elkaim, Arjun Sahgal, et al.
Pageof 65